NUP214 anticorps (C-Term)
-
- Antigène Voir toutes NUP214 Anticorps
- NUP214 (Nucleoporin 214kDa (NUP214))
-
Épitope
- C-Term
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp NUP214 est non-conjugé
-
Application
- Western Blotting (WB), Immunoprecipitation (IP)
- Fonction
- Rabbit anti-NUP214 Antibody, Affinity Purified
- Purification
- Affinity Purified
- Immunogène
- between AA 2050 and C-term
- Isotype
- IgG
- Top Product
- Discover our top product NUP214 Anticorps primaire
-
-
- Indications d'application
-
IP: 2 - 5 μg/mg lysate
WB: 1:2,000 - 1:10,000
- Restrictions
- For Research Use only
-
- Concentration
- 200 μg/mL
- Buffer
- Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
- Date de péremption
- 12 months
-
- Antigène
- NUP214 (Nucleoporin 214kDa (NUP214))
- Autre désignation
- NUP214 (NUP214 Produits)
- Synonymes
- anticorps CAN, anticorps CAN/Nup214, anticorps CG3820, anticorps DCAN, anticorps DNup214, anticorps Dmel\\CG3820, anticorps Nup 214, anticorps dCAN, anticorps l(2)10444, anticorps nup214, anticorps NUP214, anticorps RGD1304977, anticorps BC039282, anticorps D2H9S46E, anticorps CAIN, anticorps D9S46E, anticorps N214, anticorps p250, anticorps Nucleoporin 214kD, anticorps nucleoporin 214kDa, anticorps nucleoporin 214, anticorps Nup214, anticorps NUP214
- Sujet
- Background: Nucleoporins are the main components of the nuclear pore complex that provides a conduit across the nuclear envelope for the transport of macromolecules between the nucleus and cytoplasm. Nucleoporin 214 (NUP214) is required for CRM1-mediated nuclear protein export as well as cell cycle progression.
- ID gène
- 8021
- NCBI Accession
- NP_005076
- UniProt
- P35658
- Pathways
- Protein targeting to Nucleus, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
-